Godavari Biorefineries is currently trading at Rs. 361.30, up by 16.00 points or 4.63% from its previous closing of Rs. 345.30 on the BSE.
The scrip opened at Rs. 346.90 and has touched a high and low of Rs. 367.80 and Rs. 346.90 respectively. So far 38658 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 372.05 on 07-Nov-2024 and a 52 week low of Rs. 272.75 on 22-Nov-2024.
Last one week high and low of the scrip stood at Rs. 367.80 and Rs. 329.05 respectively. The current market cap of the company is Rs. 1867.41 crore.
The promoters holding in the company stood at 77.44%, while Institutions and Non-Institutions held 13.09% and 9.46% respectively.
Godavari Biorefineries (GBL) has signed a strategic international license agreement with Catalyxx Inc. This partnership grants GBL exclusive rights to leverage Catalyxx’s cutting-edge technology for the conversion of ethanol to for up to 30,000 tons of biobutanol and other higher alcohols.
Godavari will in the first phase, construct and operate a state-of-the-art facility designed to produce 15,000 metric tons of biobutanol and higher alcohols annually, marking a significant milestone in the company’s commitment to decarbonisation and sustainability.
Godavari Biorefineries is one of the manufacturers of ethanol based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.
